DOTA-MIPA

CAS:1006711-09-5

Molecular Weight:526.24

Appearance:White to of-white powder

Application:Medical intermediate

Delivery Time:Customized

Package:inside:double PE bag  outside:paper drum

Port:Any port in China

Purity:≥95%

Storage:Store at 2-8℃

Transportation:CIF by air or DAP by courier, FOB, EX W Etc...

For set production, sales, research and development as one of the manufacturers.  At present, the company has 2400 square meters of RESEARCH and development center, 1000 square meters of production workshop.  Plan to build 12000 square meters of production base, according to GMP standard quality system management.  In recent years, Pukang pharmaceutical has been approved by well-known pharmaceutical enterprises at home and abroad for more than ten times.  The main products of the company are high purity single molecule polyethylene glycol derivatives, long-term drug side chains of polypeptides and their intermediates (including cimerlutide side chains, Liraglutide side chains, insulin Degludec side chains, human growth hormone side chains, etc.), short peptide drug modified side chains (dipeptide, tetrapeptide).  The company is cooperating with innovation Pharmaceutical company to establish a long-term peptide drug development platform, committed to building a systematic variety of long-term peptide side chain library, establish long-term peptide side chain molecular blocks, and provide customers with a variety of long-term peptide drug development solutions.  Companies adhering to the "quality first, technology first" concept, to provide customers around the world with the best products and the best service.  

CAS:1006711-09-5

Molecular Weight:526.24

Appearance:White to of-white powder

Application:Medical intermediate

Delivery Time:Customized

Package:inside:double PE bag  outside:paper drum

Port:Any port in China

Purity:≥95%

Storage:Store at 2-8℃

Transportation:CIF by air or DAP by courier, FOB, EX W Etc...

For set production, sales, research and development as one of the manufacturers.  At present, the company has 2400 square meters of RESEARCH and development center, 1000 square meters of production workshop.  Plan to build 12000 square meters of production base, according to GMP standard quality system management.  In recent years, Pukang pharmaceutical has been approved by well-known pharmaceutical enterprises at home and abroad for more than ten times.  The main products of the company are high purity single molecule polyethylene glycol derivatives, long-term drug side chains of polypeptides and their intermediates (including cimerlutide side chains, Liraglutide side chains, insulin Degludec side chains, human growth hormone side chains, etc.), short peptide drug modified side chains (dipeptide, tetrapeptide).  The company is cooperating with innovation Pharmaceutical company to establish a long-term peptide drug development platform, committed to building a systematic variety of long-term peptide side chain library, establish long-term peptide side chain molecular blocks, and provide customers with a variety of long-term peptide drug development solutions.  Companies adhering to the "quality first, technology first" concept, to provide customers around the world with the best products and the best service.